- Home
- VTRS vs BLDR Comparison
VTRS vs BLDR Comparison
Compare VTRS & BLDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTRS
- BLDR
- Stock Information
- Founded
- VTRS 1961
- BLDR 1998
- Country
- VTRS United States
- BLDR United States
- Employees
- VTRS N/A
- BLDR N/A
- Industry
- VTRS Medicinal Chemicals and Botanical Products
- BLDR RETAIL: Building Materials
- Sector
- VTRS Health Care
- BLDR Consumer Discretionary
- Exchange
- VTRS Nasdaq
- BLDR Nasdaq
- Market Cap
- VTRS 10.6B
- BLDR 12.4B
- IPO Year
- VTRS N/A
- BLDR 2005
- Fundamental
- Price
- VTRS $9.37
- BLDR $134.79
- Analyst Decision
- VTRS Hold
- BLDR Strong Buy
- Analyst Count
- VTRS 5
- BLDR 19
- Target Price
- VTRS $10.40
- BLDR $162.79
- AVG Volume (30 Days)
- VTRS 9.5M
- BLDR 2.1M
- Earning Date
- VTRS 08-07-2025
- BLDR 07-31-2025
- Dividend Yield
- VTRS 5.13%
- BLDR N/A
- EPS Growth
- VTRS N/A
- BLDR N/A
- EPS
- VTRS N/A
- BLDR 7.84
- Revenue
- VTRS $14,330,200,000.00
- BLDR $16,166,636,000.00
- Revenue This Year
- VTRS N/A
- BLDR $1.50
- Revenue Next Year
- VTRS $1.85
- BLDR $2.79
- P/E Ratio
- VTRS N/A
- BLDR $17.19
- Revenue Growth
- VTRS N/A
- BLDR N/A
- 52 Week Low
- VTRS $6.85
- BLDR $102.60
- 52 Week High
- VTRS $13.55
- BLDR $203.14
- Technical
- Relative Strength Index (RSI)
- VTRS 58.40
- BLDR 63.43
- Support Level
- VTRS $8.84
- BLDR $121.55
- Resistance Level
- VTRS $9.29
- BLDR $127.88
- Average True Range (ATR)
- VTRS 0.22
- BLDR 4.51
- MACD
- VTRS -0.01
- BLDR -0.05
- Stochastic Oscillator
- VTRS 88.33
- BLDR 84.55
About VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
About BLDR Builders FirstSource Inc.
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.